Inventor · disambiguated record
Yukinori Take
Also filed as: TAKE YUKINORI
7 granted patents·2 pending applications·33 citations·filing 2010–2023
83Inventor score
Top patents by PatentIndex Score
9 records- 0193US10947235B2Selective EP4 receptor antagonistic substance for treatment of cancerASKAT INC·Filed 2020·Granted Mar 16, 2021·3 cites·12 claims
- 0293US10611761B2Selective EP4 receptor antagonistic substance for treatment of cancerASKAT INC·Filed 2017·Granted Apr 7, 2020·7 cites·20 claims
- 0393US9688674B2Selective EP4 receptor antagonistic substance for treatment of cancerRAQUALIA PHARMA INC·Filed 2014·Granted Jun 27, 2017·7 cites·6 claims
- 0490US8921391B2Selective EP4 receptor antagonistic substance for treatment of cancerTAKE YUKINORI·Filed 2010·Granted Dec 30, 2014·13 cites·8 claims
- 0580US10973834B2EP4 inhibitors and use thereofARRYS THERAPEUTICS INC·Filed 2019·Granted Apr 13, 2021·3 cites·20 claims
- 0674US11840530B2Selective EP4 receptor antagonistic substance for treatment of cancerASKAT INC·Filed 2021·Granted Dec 12, 2023·0 cites·21 claims
- 0767US2024066040A1Ep4 inhibitors and use thereofARRYS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0857US2021290641A1Ep4 inhibitors and use thereofARRYS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0920US8980922B25-HT4 receptor agonists for the treatment of dementiaOHSHIRO HIROYUKI·Filed 2011·Granted Mar 17, 2015·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Yukinori Take files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →